Journey Medical (DERM) vs Oramed Pharmaceuticals (ORMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Oramed Pharmaceuticals (ORMP) has outperformed Journey Medical (DERM) over the past year, gaining 76.2% versus a loss of 21.2%. Oramed Pharmaceuticals is the larger company by market cap ($181.8 million vs $167.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DERM | ORMP |
|---|---|---|
| Share price | $5.95 | $4.37 |
| Market cap | $167.94M | $181.78M |
| 1-day change | -3.41% | -0.23% |
| YTD return | -22.83% | +53.33% |
| 1-year return | -21.19% | +76.21% |
| 5-year return | — | -80.19% |
| P/E ratio (TTM) | — | 1.06 |
| EPS (TTM) | $-0.22 | $4.13 |
| Dividend yield | 0.00% | 5.70% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.56 | $5.47 |
| 52-week low | $4.31 | $2.09 |
| Distance from 52-week high | -37.73% | -20.11% |
| Average volume | 181.79K | 194.48K |
| Shares outstanding | 22.22M | 41.60M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ORMP has outperformed DERM by 97.4 percentage points over the past year.
- Oramed Pharmaceuticals offers a meaningfully higher dividend yield (5.70% vs 0.00%).
DERM vs ORMP FAQ
Which is bigger, Journey Medical or Oramed Pharmaceuticals?
Oramed Pharmaceuticals (ORMP) is larger, with a market capitalization of $181.78M compared with $167.94M for Journey Medical (DERM).
Which stock has performed better over the past year, DERM or ORMP?
ORMP returned +76.21% over the past 12 months, compared with -21.19% for DERM (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Journey Medical or Oramed Pharmaceuticals?
Oramed Pharmaceuticals pays a dividend yielding 5.70%, while Journey Medical does not currently pay a regular dividend.
Are Journey Medical and Oramed Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.